Synapse - Radiology, Department of

Results (54)

Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib

Meeting Abstract

Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
Pediatric Blood and Cancer (2023)

Fulltext@MSK | Save

Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma

Journal Article

Tringale, K. R.; Wolden, S. L.; Casey, D. L.; Kushner, B. H.; Luo, L.; Pandit-Taskar, N.; Souweidane, M.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; more...
Pediatric Blood and Cancer (2023)

Fulltext@MSK | Save

Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

Meeting Abstract

Modak, S.; Pandit Taskar, N.; Kushner, B.; Zanzonico, P.; Humm, J.; Donzelli, M.; Lewis, J.; Lyashchenko, S.; Chu, B.; Larson, S.; more...
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

Radioimmunotherapy with intraventricular (131)I-omburtamab in patients with central nervous system (CNS) neuroblastoma: Interim results from a multinational trial

Meeting Abstract

Kramer, K.; Mora, J.; Bear, M.; Zanzonico, P.; Pandit-Taskar, N.; During, M.; Fabricius, S.; Streby, K.; Rømer, J.
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

Percutaneous ablation of malignant and locally aggressive solid tumors in pediatric patients

Journal Article

El Hawari, M.; Moussa, A.; Erinjeri, J. P.; Ziv, E.; Maybody, M.; Santos Martin, E. G.; Solomon, S. B.; Gonzalez‐Aguirre, A. J.
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

Pneumatosis intestinalis in the pediatric oncology population: An 11‐year retrospective review at Memorial Sloan Kettering Cancer Center

Journal Article

Bailey, K. A.; Kodikara, H.; Mauguen, A.; Price, A.; LaQuaglia, M.; Boulad, F.
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

Skeletal muscle metastases in neuroblastoma: An ostensible "forme fruste" of stage MS disease

Meeting Abstract

Fong, C.; Kushner, B.; Di Giannatale, A.; Roberts, S.; Basu, E.; Price, A.; Cheung, N. K.; Modak, S.
Pediatric Blood and Cancer (2021)

Fulltext@MSK | Save

Reactive regional lymphadenopathy associated with neuroblastoma immunotherapy

Meeting Abstract

Lentini-Rivera, A.; Kushner, B.; Modak, S.; Price, A.
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save

DEBIO1347, an oral FGFR inhibitor: Results from a single center study in recurrent/refractory FGFR altered pediatric gliomas

Meeting Abstract

Karajannis, M.; Sait, S.; Gilheeney, S.; Haque, S.; Dunkel, I.
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save

High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial

Meeting Abstract

Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save